catechin has been researched along with galangin in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (21.74) | 18.2507 |
| 2000's | 7 (30.43) | 29.6817 |
| 2010's | 9 (39.13) | 24.3611 |
| 2020's | 2 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| Ash, K; Grohmann, K; Manthey, CL; Manthey, JA; Montanari, A | 1 |
| Strassburg, CP; Tukey, RH | 1 |
| Amić, D; Lucić, B | 1 |
| Kalra, S; Khatik, GL; Kumar, GN; Kumar, R; Narang, R; Nayak, SK; Singh, SK; Sudhakar, K | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Constantinou, A; Mehta, R; Moon, R; Rao, K; Runyan, C; Vaughan, A | 1 |
| Chen, K; Cheng, YC; Hu, CQ; Kilkuskie, RE; Lee, KH; Shi, Q | 1 |
| Calomme, M; Cimanga, K; Cos, P; Hu, JP; Pieters, L; Van Poel, B; Vanden Berghe, D; Vlietinck, AJ; Ying, L | 1 |
| Backlund, A; Bohlin, L; Gottfries, J; Larsson, J | 1 |
| Brun, R; Lack, G; Perozzo, R; Rüedi, P; Scapozza, L; Tasdemir, D | 1 |
| Domina, NG; Khlebnikov, AI; Kirpotina, LN; Quinn, MT; Schepetkin, IA | 1 |
| Carver, JA; Duggan, PJ; Ecroyd, H; Liu, Y; Meyer, AG; Tranberg, CE | 1 |
| Cai, S; Chu, L; Gao, F; Ji, B; Jia, G; Liu, J; Liu, Y; Wang, A; Wei, Y; Wu, W; Xie, L; Zhang, D; Zhou, F | 1 |
| Bicknell, KA; Farrimond, JA; Putnam, SE; Swioklo, S; Watson, KA; Williamson, EM | 1 |
| Calil, FA; Chibli, LA; Da Costa, FB; Nonato, MC; Schmidt, TJ | 1 |
| Jin, YS | 1 |
| Price, KR; Rhodes, MJ; Uda, Y; Williamson, G | 1 |
| De Giovani, WF; de Souza, RF | 1 |
| Curti, C; Dorta, DJ; Helena, AF; Mingatto, FE; Pigoso, AA; Prado, IM; Rodrigues, T; Santos, AC; Uyemura, SA | 1 |
| Fujita, Y; Hirooka, K; Kumamoto, K; Kunikane, S; Matsuoka, H; Tojo, S; Yoshida, K | 1 |
| Dong, Y; Li, K; Li, X; Peng, Y; Wang, M; Xing, S | 1 |
| Jang, S; Kim, HJ; Kim, T; Park, SH; Song, HK | 1 |
| Brahmasundari, S; Madeswaran, A; Midhuna, PG | 1 |
3 review(s) available for catechin and galangin
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
Recent advancements in mechanistic studies and structure activity relationship of F
Topics: Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Proton-Translocating ATPases; Structure-Activity Relationship | 2019 |
Recent advances in natural antifungal flavonoids and their derivatives.
Topics: Antifungal Agents; Biological Products; Flavonoids; Fungi; Humans; Mycoses | 2019 |
20 other study(ies) available for catechin and galangin
| Article | Year |
|---|---|
Polymethoxylated flavones derived from citrus suppress tumor necrosis factor-alpha expression by human monocytes.
Topics: Citrus; Cyclic AMP; Flavonoids; Humans; In Vitro Techniques; Lipopolysaccharides; Monocytes; Phosphodiesterase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha | 1999 |
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
Topics: Flavonoids; Free Radical Scavengers; Models, Biological; Quantitative Structure-Activity Relationship; Quantum Theory; Software; Thermodynamics | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships.
Topics: DNA Damage; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Electrophoresis, Agar Gel; Flavonoids; Hydroxylation; Plasmids; Protein Conformation; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1995 |
Anti-AIDS agents, 10. Acacetin-7-O-beta-D-galactopyranoside, an anti-HIV principle from Chrysanthemum morifolium and a structure-activity correlation with some related flavonoids.
Topics: Antiviral Agents; Cells, Cultured; Flavonoids; Galactosides; HIV-1; Humans; Mass Spectrometry; Medicine, Chinese Traditional; Plants, Medicinal; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Structure-Activity Relationship; Virus Replication; Zidovudine | 1994 |
Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers.
Topics: Enzyme Inhibitors; Flavonoids; Free Radical Scavengers; Structure-Activity Relationship; Xanthine Oxidase | 1998 |
Expanding the ChemGPS chemical space with natural products.
Topics: Biological Products; Combinatorial Chemistry Techniques; Computer Graphics; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Molecular Structure; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship | 2005 |
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Reductase; Alcohol Oxidoreductases; Animals; Antimalarials; Catechin; Cells, Cultured; Chloroquine; Drug Resistance; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Fatty Acids; Flavones; Flavonoids; Humans; Hydro-Lyases; Kinetics; Luteolin; Phenols; Plasmodium falciparum; Polyphenols; Structure-Activity Relationship | 2006 |
Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems.
Topics: Animals; Antioxidants; Drug Design; Flavonoids; Humans; Phagocytes; Phenols; Polyphenols; Quantitative Structure-Activity Relationship | 2007 |
Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formation.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Caseins; Flavonoids; Humans; Methylation; Milk; Structure-Activity Relationship | 2010 |
Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis in vitro.
Topics: Antioxidants; Cell Line; Fatty Liver; Flavonoids; Humans; In Vitro Techniques; Oleic Acid; Reactive Oxygen Species; Triglycerides | 2011 |
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
Topics: Cell Differentiation; Flavonoids; Humans; Mesenchymal Stem Cells; Molecular Structure; Osteogenesis; Signal Transduction; Structure-Activity Relationship | 2015 |
Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase.
Topics: Biological Products; Calorimetry, Differential Scanning; Dihydroorotate Dehydrogenase; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Lactones; Leishmania major; Models, Molecular; Molecular Structure; Oxidoreductases Acting on CH-CH Group Donors; Quantitative Structure-Activity Relationship; Sesquiterpenes | 2018 |
Induction of the anticarcinogenic marker enzyme, quinone reductase, in murine hepatoma cells in vitro by flavonoids.
Topics: Animals; Catechin; Chamomile; Enzyme Induction; Enzyme Inhibitors; Flavonoids; Flavonols; Kaempferols; Liver Neoplasms, Experimental; Mice; NAD(P)H Dehydrogenase (Quinone); Oils, Volatile; Plants, Medicinal; Quercetin; Tumor Cells, Cultured | 1997 |
Antioxidant properties of complexes of flavonoids with metal ions.
Topics: Antioxidants; Ascorbic Acid; Biphenyl Compounds; Catechin; Drug Synergism; Flavonoids; Free Radical Scavengers; Magnetic Resonance Spectroscopy; Metals; Oxidation-Reduction; Picrates; Quercetin; Reactive Oxygen Species; Rutin; Superoxide Dismutase | 2004 |
The interaction of flavonoids with mitochondria: effects on energetic processes.
Topics: Adenosine Triphosphate; Animals; Calcium; Catechin; Cell Respiration; Flavonoids; Flavonols; Intracellular Membranes; Luminescent Measurements; Male; Membrane Fluidity; Mitochondria, Liver; Polarography; Quercetin; Rats; Rats, Wistar; Structure-Activity Relationship | 2005 |
Dual regulation of the Bacillus subtilis regulon comprising the lmrAB and yxaGH operons and yxaF gene by two transcriptional repressors, LmrA and YxaF, in response to flavonoids.
Topics: Amino Acid Sequence; Bacillus subtilis; Bacterial Proteins; Base Sequence; Catechin; Dioxygenases; Disaccharides; DNA Footprinting; Electrophoretic Mobility Shift Assay; Flavonoids; Flavonols; Gene Expression Regulation, Bacterial; Lincomycin; Molecular Sequence Data; Molecular Structure; Oligonucleotide Array Sequence Analysis; Operon; Promoter Regions, Genetic; Protein Binding; Quercetin; Regulon; Repressor Proteins; Sequence Homology, Amino Acid | 2007 |
Anticomplement and antimicrobial activities of flavonoids from Entada phaseoloides.
Topics: Anti-Infective Agents; Catechin; Complement Inactivator Proteins; Enterococcus; Fabaceae; Flavanones; Flavonoids; Methicillin-Resistant Staphylococcus aureus; Molecular Structure; Quercetin | 2012 |
Alpinia officinarum water extract inhibits the atopic dermatitis-like responses in NC/Nga mice by regulation of inflammatory chemokine production.
Topics: Alpinia; Animals; Anti-Inflammatory Agents; Antigens, Dermatophagoides; Arthropod Proteins; Catechin; Chemokines; Dermatitis, Atopic; Dermatophagoides farinae; Disease Models, Animal; Flavonoids; HaCaT Cells; Humans; Hydroxybenzoates; Keratinocytes; Male; Mice; Plant Extracts; Signal Transduction; Skin; Solvents; Water | 2021 |
In silico molecular docking studies of certain commercially available flavonoids as effective antiviral agents against spike glycoprotein of SARS-CoV-2.
Topics: Antiviral Agents; Binding Sites; Catechin; COVID-19; Flavanones; Flavonoids; Humans; Molecular Docking Simulation; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2021 |